|
시장보고서
상품코드
2078874
뇌하수체암 시장 : 암 종류별, 호르몬 종류별, 치료법별, 연령층별, 최종사용자별, 지역별Pituitary Cancer Market, By Cancer Type, By Hormone Type, By Treatment Type, By Age Group, By End User, By Geography |
||||||
가격
※ 부가세 별도
한글목차
영문목차
※ 본 상품은 영문 자료로 한글과 영문 목차에 불일치하는 내용이 있을 경우 영문을 우선합니다. 정확한 검토를 위해 영문 목차를 참고해주시기 바랍니다.
뇌하수체암 시장은 2026년에 5억 250만 달러 규모가 될 것으로 추정되며, 2033년까지 9억 6,690만 달러에 달할 것으로 예상됩니다. 2026년부터 2033년까지 CAGR 9.8%로 성장할 것으로 전망됩니다.
| 분석 범위 | 분석 상세 | ||
|---|---|---|---|
| 기준 연도 | 2025년 | 시장 규모(2026년) | 5억 250만 달러 |
| 실적 데이터 | 2020-2024년 | 예측 기간 | 2026-2033년 |
| 예측 기간 CAGR(2026-2033년) | 9.80% | 예측 금액(2033년) | 9억 6,690만 달러 |
뇌하수체암의 원인에 대해서는 아직 충분히 밝혀지지 않았습니다. 그러나 유전적 요인이나 호르몬 불균형이 영향을 미쳤을 가능성이 있습니다. 뇌하수체 종양의 대부분은 선종, 즉 비암성입니다. 이러한 증상은 마찬가지로 양성(비암성)인 뇌하수체 낭종만큼 흔하지는 않습니다.
뇌하수체암의 증상으로는 두통, 시력 변화, 체중 감소 또는 체중 증가의 어려움, 기억력 및 집중력 저하 등이 흔히 나타납니다. 뇌하수체 종양의 종류에 따라 과도한 호르몬을 분비하여 쿠싱 증후군이라는 질환을 유발할 수 있습니다. 경우에 따라 이 질환으로 인해 체내에서 프로락틴이 과다 분비되어 가슴이나 팔의 피부가 얇아지거나, 다리나 발의 뼈가 약해질 수 있습니다. 또한, 이 질환의 다른 형태에서는 임신하지 않았음에도 불구하고 유방에서 모유가 분비되는 경우가 있습니다. 또한, 이 질환은 혈압에 광범위한 변화를 일으킬 가능성이 있으며, 안면 홍조나 팔·다리의 고혈압 등이 나타날 수도 있습니다.
시장 역학:
뇌하수체 종양 발생률의 증가, 연구개발 활동에 대한 투자 확대, 그리고 치료법의 기술적 진보가 예측 기간 동안 전 세계 뇌하수체암 시장의 성장을 견인할 것으로 예상됩니다. 또한, 일반 시민들의 인식이 높아짐에 따라 비침습적 치료법에 대한 수요가 증가하고 있습니다. 또한, 뇌하수체 종양에 대한 전문적인 서비스를 제공하는 병원 및 진료소의 증가도 시장 성장을 뒷받침하고 있습니다.
그러나 암 치료의 높은 비용은 예측 기간 동안 전 세계 뇌하수체암 시장의 성장을 저해할 것으로 예상되는 주요 요인입니다.
본 보고서의 주요 특징
- 본 보고서는 각 부문의 잠재적 수익 기회를 밝히고, 이 시장의 매력적인 투자 제안 매트릭스에 대해 설명하고 있습니다.
- 또한, 시장의 촉진요인 및 억제요인, 기회, 신제품 출시 및 승인, 시장 동향, 지역별 전망, 주요 기업들이 채택하는 경쟁 전략 등에 관한 중요한 인사이트도 제공하고 있습니다.
- 전 세계 뇌하수체암 시장의 주요 기업 개요을 각종 지표(기업 개요, 제품 포트폴리오, 주요 동향, 재무 실적, 전략 등)를 바탕으로 수록하고 있습니다.
- 본 보고서의 인사이트를 바탕으로, 마케팅 담당자와 기업 경영진은 향후 제품 출시, 기술 업데이트, 시장 확대 및 마케팅 전략에 대해 충분한 정보를 바탕으로 의사결정을 내릴 수 있습니다.
- '세계 뇌하수체암 시장' 보고서는 투자자, 공급업체, 제품 제조업체, 유통업체, 신규 진입 기업, 재무 분석가 등 이 업계의 다양한 이해관계자들을 대상으로 합니다.
- 이해관계자들은 전 세계 뇌하수체암 시장 분석에 사용되는 다양한 전략 매트릭스를 통해 의사결정을 보다 수월하게 할 수 있습니다.
목차
제1장 분석 목적과 가정
제2장 시장 전망
제3장 시장 역학·규제·동향 분석
제4장 뇌하수체암
제5장 뇌하수체암 시장 : 암 종류별(2021-2033년)
제6장 뇌하수체암 시장 : 호르몬 종류별(2021-2033년)
제7장 뇌하수체암 시장 : 치료법별(2021-2033년)
제8장 뇌하수체암 시장 : 연령층별(2021-2033년)
제9장 뇌하수체암 시장 : 최종사용자별(2021-2033년)
제10장 뇌하수체암 시장 : 지역별(2021-2033년)
제11장 경쟁 구도
제12장 섹션
KSM 26.07.15Pituitary Cancer Market is estimated to be valued at USD 502.5 Mn in 2026 and is expected to reach USD 966.9 Mn by 2033, growing at a compound annual growth rate (CAGR) of 9.8% from 2026 to 2033.
| Report Coverage | Report Details | ||
|---|---|---|---|
| Base Year: | 2025 | Market Size in 2026: | USD 502.5 Mn |
| Historical Data for: | 2020 To 2024 | Forecast Period: | 2026 To 2033 |
| Forecast Period 2026 to 2033 CAGR: | 9.80% | 2033 Value Projection: | USD 966.9 Mn |
The cause of pituitary cancer is not well understood. But genetics and hormonal imbalances may play a role. Most pituitary tumors are adenomas, or noncancerous. They are not as common as pituitary gland cysts, which are benign (noncancerous).
Symptoms of pituitary cancer often include headaches, vision changes, loss of weight or an inability to gain weight, and trouble with memory and concentration. Some types of pituitary tumors release too many hormones, which can lead to a disease called Cushing's syndrome. In some cases, this disease causes the body to produce too much prolactin, which can cause thinning of the skin in the chest and arms, and weak bones in the legs and feet. Other forms of this condition can cause the breasts to make milk, even when the person is not pregnant. The condition can also cause a wide range of changes in blood pressure, including a flushed face and high blood pressure in the arms or legs.
Market Dynamics:
Rising incidences of pituitary tumors, increasing investments in research and development activities, and technological advancements in treatment methods are expected to drive growth of the global pituitary cancer market during the forecast period. In addition, increased awareness among the populace has led to a higher demand for noninvasive treatments. The market is also driven by a rise in the number of hospitals and clinics that offer specialized services for pituitary tumors.
However, the high cost of cancer treatments is a major factor expected to impede the growth of the global pituitary cancer market over the forecast period.
Key features of the study:
- It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market
- This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players
- It profiles key players in the global pituitary cancer market based on the following parameters - company highlights, products portfolio, key highlights, financial performance, and strategies
- Key companies covered as a part of this study include Novartis International AG, Pfizer Inc., Ipsen Biopharmaceuticals, Inc., Endocyte, RECORDATI GROUP, Camurus AB, Endeavor Biomedicines, Inc., and Debiopharm International SA
- Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics
- The global pituitary cancer market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts
- Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global pituitary cancer market
Global Pituitary Cancer Market Detailed Segmentation:
- By Cancer Type:
- Pituitary Adenoma (Benign Tumor)
- Pituitary Carcinoma (Malignant Tumor)
- By Hormone Type:
- Prolactinoma
- Growth Hormone-Secreting Tumor (Acromegaly)
- Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
- Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
- Gonadotropin-Secreting Tumor
- By Treatment Type:
- Surgery
- Radiation Therapy
- Medications (e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
- Targeted Therapy
- Chemotherapy
- By Age Group:
- Pediatric
- Adult
- By End User:
- Hospitals
- Specialty Clinics
- Cancer Treatment Centers
- Research Institutes
- By Region:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
- Company Profile:
- Novartis International AG
- Pfizer Inc.
- Ipsen Biopharmaceuticals, Inc.
- Endocyte
- RECORDATI GROUP
- Camurus AB
- Endeavor Biomedicines, Inc.
- Debiopharm International SA
Table of Contents
1. Research Objectives and Assumptions
- Research Objectives
- Assumptions
- Abbreviations
2. Market Purview
- Report Description
- Market Definition and Scope
- Executive Summary
- Market Pituitary Cancer, By Cancer Type
- Market Pituitary Cancer, By Hormone Type
- Market Pituitary Cancer, By Treatment Type
- Market Pituitary Cancer, By Age Group
- Market Pituitary Cancer, By End User
- Market Pituitary Cancer, By Region
- Coherent Opportunity Map (COM)
3. Market Dynamics, Regulations, and Trends Analysis
- Market Dynamics
- Drivers
- Increasing Incidence and Prevalence
- Advancements in Medical Imaging and Diagnostics
- Increased Research and Development
- Growing Demand for Personalized Medicine
- Restraints
- Limited Awareness and Delayed Diagnosis
- Lack of Standardized Treatment Guidelines
- Limited Treatment Options for Aggressive Pituitary Cancers
- Challenges in Drug Development
- Opportunities
- Development of Targeted Therapies
- Combination Therapies
- Advancements in Surgical Techniques
- Development of Novel Imaging Modalities
- Drivers
- Impact Analysis
- Key Highlights
- Regulatory Scenario
- Product launch/Approvals
- PEST Analysis
- PORTER€(TM)s Analysis
- Merger and Acquisition Scenario
4. Pituitary Cancer
- Supply Side and Demand Side Analysis
- Economic Impact
5. Pituitary Cancer Market , By Cancer Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Pituitary Adenoma (Benign Tumor)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
- Pituitary Carcinoma (Malignant Tumor)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Mn)
6. Pituitary Cancer Market , By Hormone Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2026 and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Prolactinoma
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Growth Hormone-Secreting Tumor (Acromegaly)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Adrenocorticotropic Hormone-Secreting Tumor (Cushing's Disease)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Thyroid-Stimulating Hormone-Secreting Tumor (TSHoma)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Gonadotropin-Secreting Tumor
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
7. Pituitary Cancer Market , By Treatment Type, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022€" 2033
- Segment Trends
- Surgery
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Radiation Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Medications(e.g., dopamine agonists, somatostatin analogs, hormone replacement therapy)
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Targeted Therapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Chemotherapy
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
8. Pituitary Cancer Market , By Age Group, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Pediatric
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Adult
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
9. Pituitary Cancer Market , By End User, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, 2023and 2033 (%)
- Y-o-Y Growth Analysis, 2022€"2033
- Segment Trends
- Hospitals
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Specialty Clinics
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Cancer Treatment Centers
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
- Research Institutes
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, 2021 - 2033,(US$ Million)
10. Pituitary Cancer Market , By Region, 2021 - 2033, (US$ Mn)
- Introduction
- Market Share Analysis, By Country, 2023and 2033 (%)
- Y-o-Y Growth Analysis, For Country 2022€"2033
- Country Trends
- North America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- U.S.
- Canada
- Europe
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- U.K.
- Germany
- Italy
- France
- Spain
- Russia
- Rest of Europe
- Asia Pacific
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- China
- India
- Japan
- ASEAN
- Australia
- South Korea
- Rest of Asia Pacific
- Latin America
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- Brazil
- Mexico
- Argentina
- Rest of Latin America
- Middle East & Africa
- Introduction
- Market Size and Forecast, and Y-o-Y Growth, By Cancer Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Hormone Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Treatment Type, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By Age Group, 2021 - 2033,(US$ Mn)
- Market Size and Forecast, and Y-o-Y Growth, By End User, 2021 - 2033,(US$ Mn)
- GCC
- Israel
- North Africa
- Central Africa
- Rest of Middle East & Africa
11. Competitive Landscape
- Novartis International AG
- Company Highlights
- Product Portfolio
- Key Developments
- Financial Performance
- Strategies
- Pfizer Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Ipsen Biopharmaceuticals, Inc.
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Endocyte
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- RECORDATI GROUP
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Camurus AB
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Endeavor Biomedicines, Inc
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Debiopharm International SA
- Company Highlights
- Product Portfolio
- Key Highlights
- Financial Performance
- Strategies
- Analyst Views
12. Section
- Research Methodology
- About us
